Those investors who missed out on the huge run-ups in publicly traded cannabis stocks get another opportunity to partake in the booming market.
The IPO Terms
Calgary, Alberta-based Sundial Growers Inc. is planning to offer 10 million shares in an IPO, with the pricing of the offering estimated between $12 and $14 per share, a F-1/A filing revealed.
At the midpoint of the estimated price range, the size of the offering is $130 million.
The company has applied for listing its shares on the Nasdaq under the ticker symbol SNDL.
Cowen, BMO Capital Markets and RBC Capital Markets are the lead underwriters for the offering.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
The Company
Cannabis grower Sundial currently produces and markets premium cannabis for recreational use under the Sundial Cannabis brand in Canada. The company has been approved to supply cannabis directly to retailers by five provincial regulating authorities in Canada.
Sundial said it intends to offer products under its Top Leaf and BC Weed Co. brands, among others.
The company also said it plans to enter the CBD market through its acquisition of Bridge Farm, an indoor agricultural producer of edible herbs and ornamental flowers in the U.K. in July. Additionally, it has tie-ups with Canadian research institutions, as well as a joint venture with Pathway Rx to identify and develop cannabis strains for medicinal use.
Citing estimates by the U.N., Sundial said it estimates the global legal and illicit cannabis market to be $150 million, annually.
The Finances
Sundial has not reported revenues for the fiscal year ended Dec. 31, 2018 but recorded a loss of $56.53 million for the year.
For the three months ended March 31, 2019, the company reported net revenues of $1.50 million compared to no revenues in the year-ago quarter. The loss, however, widened from $7.15 million to $16.70 million.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
